Skip to main content
Premium Trial:

Request an Annual Quote

Akoya Biosciences Closes $50M Funding Round

NEW YORK – Akoya Biosciences said today that it has closed a $50 million funding round.

The Menlo Park, California-based company plans to use the proceeds to fund operation and commercial growth as well as development of its Codex and Phenoptics spatial omics platforms.

The financing was led by Piper Jaffray Merchant Banking and included previous investor Telegraph Hill Partners. New investors included Agilent Technologies and Innovatus Capital Partners. It follows a 2018 Series C round that Akoya used to fund the $37 million acquisition of PerkinElmer's Phenoptics portfolio.

"Akoya is transforming how immunotherapies are developed, from discovery of novel biomarkers in the tumor microenvironment, to deploying high-throughput, highly sensitive information to direct patient therapies." Thomas Schnettler, managing director at Piper Jaffray, said in a statement. "Our investment represents our confidence in Akoya's relentless execution to deliver the next generation of pathology tools."

Schnettler has also joined Akoya's board of directors.

Akoya's platforms allow for multiplexed imaging of protein markers at the single-cell level.

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.